Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04730609 · ClinicalTrials.gov registry record · Phase 4
Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery
A Phase 4 study of Shivering and Dose Finding Study, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT04730609: Recruiting Phase 4 study of Shivering and Dose Finding Study, sponsored by Mayo Clinic.
NCT04730609 is a Phase 4 study of Shivering and Dose Finding Study that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 40 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04730609, a Phase 4 study of Shivering and Dose Finding Study, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
Primary Outcome
Cessation of shivering
Conditions Studied
Interventions
- DRUG Dexmedetomidine
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-09-21 |
| Est. Completion | 2026-08 |
| Phase | Phase 4 |
What NCT04730609 shows while recruiting
NCT04730609 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Shivering appearing as the primary indexed condition, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT04730609 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04730609 about?
NCT04730609 is a clinical study titled "Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery". The purpose of this study is to determine the optimum dose of Dexmedetomidine to stop shivering in 90% of patients who experience shivering during scheduled elective cesarean deliveries.
What is the current status of trial NCT04730609?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2021-09-21. Estimated completion is 2026-08.
What conditions does trial NCT04730609 study?
This clinical trial studies the following conditions: Shivering, Dose Finding Study.
What interventions are being tested in trial NCT04730609?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT04730609?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04730609 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04730609's enrollment target sits among peer trials
40 1397th of 2000 higher than 534 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI